Inovalon Announces Second Quarter 2021 Earnings Conference Call
Inovalon (Nasdaq: INOV) announced it will conduct a conference call on July 28, 2021, at 5:00 p.m. ET to review its second quarter 2021 financial results. This call follows the release of its financial results and will be accessible at (855) 783-2604, with international callers using (631) 485-4882. Investors can also access a replay on Inovalon's website. The company emphasizes its role in data-driven healthcare through the Inovalon ONE® Platform, connecting healthcare data and analytics for improved patient care and financial performance.
- Upcoming conference call indicates transparency with investors.
- Inovalon's technology supports thousands of clients, enhancing credibility.
- Specific financial results are yet to be disclosed, creating uncertainty.
BOWIE, Md., July 14, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a conference call for investors on Wednesday, July 28, 2021, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the Company’s second quarter 2021 financial results, which will be announced via press release after the close of market trading.
The conference call can be accessed by dialing (855) 783-2604, conference ID 4583925; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com.
About Inovalon
Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including all 25 of the top 25 U.S. health plans, all 25 of the top 25 global pharma companies, 24 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 580,000 clinical facilities, 336 million Americans, and 62 billion medical events. For more information, visit www.inovalon.com.
Contact:
Kim E. Collins
Senior Vice President, Corporate Communications
kcollins@inovalon.com
301-809-4000 x1473
Hulus Alpay
Vice President, Investor Relations
halpay@inovalon.com
301-809-4000 x1237
FAQ
When will Inovalon announce its second quarter 2021 financial results?
How can I access the Inovalon conference call?
What is the purpose of Inovalon's upcoming conference call?
What is the ticker symbol for Inovalon?
